OptiNose OPTN 深 沪
已收盘 05-21 16:00:00 美东时间
9.60
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 9.60
- 总市值 9722.30万
- 52周最高 20.025
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 4.815
- 委 比 0.00%
- 总股本 1012.74万
- 历史最高 450.00
- 量 比 0
- 振 幅 0.00%
- 历史最低 4.815
- 每 手 1
- 风险率 2.44%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Option Care Health Announces Chief Financial Officer Transition
<p>Option Care Health announced that Mike Shapiro will step down as CFO after 10 years of service, effective September 30, 2025. He will transition into a strategic advisor role. Meenal Sethna, a seasoned CFO with over 30 years of experience across multiple industries, will succeed him as Executive Vice President and CFO effective October 1, 2025. Sethna joins from Littelfuse, Inc., where she served as CFO. The company expressed excitement over S...
08-20 12:45
'HHS Finds Systemic Disregard for Sanctity of Life in Organ Transplant System; To Begin Reforming Organ Transplant System; HRSA's Independent Investigation Revealed Clear Negligence After Previous OPTN Board Claimed To Find No Major Concerns In Internal Review'
https://www.hhs.gov/press-room/hrsa-to-reform-organ-transplant-system.html#:~:text=It%20found%3A,serious%20ethical%20and%20legal%20questions.
07-22 01:17
Optinose Acquired by Paratek Pharmaceuticals for $330 Million
Optinose ( ($OPTN) ) has provided an update. Optinose, a company involved in th...
05-21 20:57
美股大行评级 | 摩根大通：维持网易"超配"评级，目标价升至135美元；瑞银上调达美航空评级至"买入"
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1131517965561573377.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持Armata Pharmaceuticals(ARMP)"买入"评级，目标价从7美元升至9美元</p> <p>• 瑞银：维持爱芬奇(ANF)"买入"评级，目标价从115美
05-20 09:28
HC Wainwright & Co. Reiterates Neutral on OptiNose, Maintains $9 Price Target
HC Wainwright & Co. analyst Matthew Caufield reiterates OptiNose (NASDAQ:OPTN) with a Neutral and maintains $9 price target.
05-19 18:39
Optinose Stockholders Approve Merger with Paratek
Optinose ( ($OPTN) ) just unveiled an update. On May 16, 2025, OptiNose, Inc. h...
05-17 00:57
OptiNose GAAP EPS of -$0.03 beats by $0.76, revenue of $22.42M beats by $1.6M
OptiNose press release (NASDAQ:OPTN): Q4 GAAP EPS of -$0.03 beats by $0.76. Revenue of $22.42M (+12.8% Y/Y) beats by $1.6M. The company had cash and cash equivalents of $84.5 million as of December 31...
03-26 19:26
美股大行评级 | 高盛：上调Adaptive Biotechnologies评级至"买入"，目标价从8美元升至9美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1110125309827231744.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Oppenheimer：维持Amprius Technologies(AMPX)"跑赢大市"评级，目标价从14美元升至15美元</p> <p>• 韦德布什：维持Monte Rosa Therapeutics(GLUE)"跑
03-24 07:31
美股大行评级 | Piper Sandler：上调ACV Auctions, Inc. Class A评级至"超配"，目标价从18美元升至20美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1109762517053050881.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持Femasys Inc Ordinary Shares(FEMY)"买入"评级，目标价从12美元升至15美元</p> <p>• Chardan Capital：维持Pri
03-21 09:11
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRA, BECN, OPTN on Behalf of Shareholders
NEW YORK, March 20, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/o...
03-21 00:31
